# Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)

> **NCT06300502** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Massachusetts General Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Neurofibromas, Cutaneous
- Neurofibromatosis 1

## Interventions

- **DRUG:** Kybella

## Key facts

- **NCT ID:** NCT06300502
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-04-08
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06300502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06300502, "Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06300502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*